Original Research
Oesophageal cancer in South Africa: The long timeline from onset of symptoms to definitive management
Submitted: 10 November 2016 | Published: 26 May 2017
About the author(s)
Morganayagi Govender, Department of Surgery, Grey’s Hospital, University of KwaZulu-Natal, South AfricaLucien Ferndale, Department of Surgery, Grey’s Hospital, University of KwaZulu-Natal, South Africa
Damian L. Clark, Department of Surgery, Grey’s Hospital, University of KwaZulu-Natal, South Africa
Abstract
Methods: It was a two-armed study of patients with oesophageal cancer seen at Greys Hospital in Pietermaritzburg. One was a retrospective chart review establishing a timeline. The second part was a prospective study between June and November 2012 where data were collected by means of patient interviews.
Results: One hundred and thirteen charts were reviewed. The time from first symptoms to definitive management ranged from 2 to 14 months (average 7 months). Forty-six patients were interviewed. All experienced dysphagia but 83% were only prompted to seek help after weight loss. The duration of symptoms prior to first clinic or hospital attendance was 0–12 months (average 3 months). The reasons for the delay included the following: 41% of patients did not consider dysphagia a significant symptom, 24% had no money, 19% sought the help of traditional healers first and 15% said the hospital was too far away.
Conclusion: There are long delays in the management of oesophageal cancer in our setting. The delays are prehospital as well as within the health care system. Lack of knowledge about oesophageal cancer symptoms and limited access to health care contributed to delays in management. Targeted quality improvement interventions are necessary. Patient education and improved referral systems are vital in encouraging earlier presentation.
Keywords
Metrics
Total abstract views: 6015Total article views: 7423
Crossref Citations
1. Time intervals from first symptom recognition to pathological diagnosis among patients with oesophageal cancer in Ethiopia: a cross-sectional study
Berhe Dessalegn, Sefonias Getachew, Robel Yirgu, Fikre Enqueselassie, Mathewos Assefa, Adamu Addissie
BMJ Open vol: 12 issue: 8 first page: e060812 year: 2022
doi: 10.1136/bmjopen-2022-060812
2. Gallbladder cancer in Africa: A higher than expected rate in a “low-risk” population
Zafar Ahmed Khan, Muhammed Uzayr Khan, Martin Brand
Surgery vol: 171 issue: 4 first page: 855 year: 2022
doi: 10.1016/j.surg.2021.09.016
3. Oesophageal cancer in South Africa: A scoping review
Lucien Ferndale, Colleen Aldous
South African Journal of Oncology vol: 6 issue: 1 year: 2022
doi: 10.4102/sajo.v6i1.217
4. Improving Access to Self-Expanding Metal Stents for Patients With Esophageal Cancer in Eastern Africa: A Stepwise Implementation Strategy
Beatrice P. Mushi, Michael M. Mwachiro, Geoffrey Buckle, Bongani N. Kaimila, Gift Mulima, Violet Kayamba, Paul Kelly, Larry Akoko, Elia J. Mmbaga, Msiba Selekwa, Yona Ringo, Natalie Pritchett, Russell E. White, Mark D. Topazian, David E. Fleischer, Sanford M. Dawsey, Katherine Van Loon
JCO Global Oncology issue: 7 first page: 118 year: 2021
doi: 10.1200/GO.20.00318



